Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer's disease treatment [23-08-2022]
Alzheimer´s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (Aβ) aggregation failed to show effectiveness in people with AD symptoms.
Related News
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
Nanobiotechnology, Nanomedicine
NBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform [19-09-2023]
Nanomedicine, Graphene
Nanoneedle breakthrough gives hope for cheaper cancer treatment [24-08-2023]
Nanomedicine, Nanotechnologies
Nanovesicles from cells for biomedical applications [17-01-2023]
Nanobiotechnology, Nanomedicine
Wireless brain implant monitors neurotransmitters in real-time [16-01-2023]
Nanomaterials, Nanobiotechnology, Nanomedicine

© Phantoms Foundation 2023